Publication of standalone quarterly report (SA-Q) for Q3/FY2026 (Q2 of the calendar year 2027)
Beginning of closed period before publication of quarterly results
Publication of standalone interim report (SA-P) for H1/ FY2026 (Q4 of the calendar year 2026 and Q1 of the calendar year 2027)
Beginning of the closed period before the publication of half-year results
Publication of standalone quarterly report (SA-Q) for Q1/FY2026 (Q4 of the calendar year 2026)
Beginning of the closed period before the publication of quarterly results
Publication of standalone annual report for FY2025 (SA-RS)
Beginning of the closed period before the publication of annual results
Publication of standalone quarterly report (SA-Q) for Q3/FY2025 (Q2 of the calendar year 2026)
Beginning of closed period before publication of quarterly results
Publication of standalone interim report (SA-P) for H1/ FY2025 (Q4 of the calendar year 2025 and Q1 of the calendar year 2026)
Beginning of the closed period before the publication of half-year results
Extraordinary Shareholder Meeting
First day of listing of Syn2bio shares on the regulated market of the WSE